A multinational coalition of stakeholders from across the medicines research and development pathway is addressing the need for a systematic and global approach to patient engagement. Members of Patient Focused Medicine Development (PFMD) discuss the need for this synergized universal approach in a recent video.

PFMD member Lode Dewulf VP, Chief Patient Affairs officer at UCB says:

‘We need to find harmonised ways to talk consistently to patients across different countries so that the results in country A are also valuable to country B so that we don’t ultimately waste time and money and delay getting the drugs to the patients that need it”


Read More